Descartes vs. nCino: Which Technology Stock Is a Better Buy in 2026?

The article contrasts Descartes (DSGX) vs. nCino (NCNO) for 2026, highlighting Descartes’ FY2026 revenue of ~$730M (+~12% YoY), net income of ~$164M, and near debt-free positioning (debt-to-equity ~0x) alongside ~$261M free cash flow. nCino reported FY2026 revenue of $594.8M (+10%) with a profitability pivot to net income of ~ $5.2M, FCF of ~$82.6M, and a higher debt-to-equity (~0.3x) inflated by stock-based compensation (~82% of operating cash flow). It also cites valuation gaps (Forward P/E 25.9x DSGX vs 14.6x NCNO; P/S 8.3x vs 3.2x) and expects fiscal 2027 upside: nCino revenue ~$645M with net income expanding to ~$38M, and Descartes revenue ~$812M (+11%) with net income ~$201M (+23%).

Analysis

Descarte wins when complexity rises: every added tariff rule, customs exception, or route disruption makes its workflow more embedded and harder to rip out. That gives it a higher-quality moat than a generic AI story, because the product is tied to operating necessity, not experimentation. The second-order winner is any logistics-adjacent vendor that monetizes uncertainty; the loser is broader suite players that can bundle on price but usually lack the same depth in compliance workflows.

nCino’s better-looking valuation is partly a function of investors paying for an AI monetization path that banks tend to adopt slowly. The real constraint is not model quality but procurement friction and the burden of switching core banking workflows, so revenue expansion could lag narrative enthusiasm for several quarters. The dependency on Salesforce is also a latent margin and negotiating risk: if the platform economics shift, the equity story compresses quickly, especially because reported cash generation is still heavily aided by non-cash add-backs.

Near term, this looks more like a relative-value setup than a broad long/short macro call. Over 1-3 months, any spike in trade policy noise or shipping disruption should favor DSGX on estimate revisions, while NCNO needs a tangible AI attach-rate or multi-product expansion update to justify multiple expansion. Over 6-18 months, the key question is whether DSGX can sustain mid-teens quality growth without trade volatility, and whether NCNO can convert AI messaging into durable gross-margin improvement rather than just higher S&M spend.

Contrarian view: consensus may be underpricing how cyclical DSGX really is and overpricing how fast NCNO’s AI pitch turns into bank budget dollars. If global trade normalizes faster than expected, DSGX’s premium could look stretched; if so, it becomes more of a hold than a chase. For NCNO, the thesis breaks if SBC stays elevated or if customer wins do not translate into FCF conversion and accelerating billings within the next 2-3 quarters.

Key Decisions for Investors

• Long DSGX / short NCNO as a 6-12 month relative-quality pair: favor the business with clearer pricing power and lower execution risk; unwind if DSGX growth falls below high-single digits for two consecutive quarters or NCNO re-accelerates billings while SBC intensity drops materially.
• Buy DSGX on pullbacks rather than strength; the cleaner entry is after any post-earnings compression if management reiterates sustained demand from trade-complexity products. Use a 12-18 month horizon and cut if global trade uncertainty eases enough to pressure forward estimates.
• Avoid initiating a fresh long in NCNO until management proves AI features are producing measurable workflow expansion, not just marketing lift. The watch item is SBC as a share of operating cash flow; if it remains elevated, treat FCF as lower quality.
• For accounts that need software exposure but want less narrative risk, rotate toward DSGX over suite names like ORCL/SAP where bundling can pressure niche vendors' pricing discipline. This is a defensive software allocation, not a high-beta AI bet.